{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:17:24Z","timestamp":1792664244520,"version":"4.5.0"},"reference-count":171,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T00:00:00Z","timestamp":1694044800000},"content-version":"am","delay-in-days":341,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006459","name":"Children's Hospital Los Angeles","doi-asserted-by":"publisher","award":["LB805"],"award-info":[{"award-number":["LB805"]}],"id":[{"id":"10.13039\/100006459","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006518","name":"University of Nebraska Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006518","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS116037"],"award-info":[{"award-number":["R01NS116037"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA266759"],"award-info":[{"award-number":["R01CA266759"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS128336"],"award-info":[{"award-number":["R01NS128336"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.jconrel.2022.08.051","type":"journal-article","created":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T05:56:12Z","timestamp":1662530172000},"page":"668-687","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":134,"special_numbering":"C","title":["Recent advances in drug delivery and targeting to the brain"],"prefix":"10.1016","volume":"350","author":[{"given":"Bharti","family":"Sethi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virender","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalika","family":"Mahato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald W.","family":"Coulter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram I.","family":"Mahato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2022.08.051_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114303","article-title":"Drug delivery across the blood-brain barrier for the treatment of pediatric brain tumors - An update","volume":"185","author":"Power","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0010","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/s41578-021-00394-w","article-title":"Drug delivery to the central nervous system","volume":"7","author":"Elizabeth Nance","year":"2022","journal-title":"Nature Rev. Mater."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0015","doi-asserted-by":"crossref","first-page":"489","DOI":"10.4155\/fmc-2018-0436","article-title":"Small molecules as central nervous system therapeutics: old challenges, new directions, and a philosophic divide","volume":"11","author":"Banks","year":"2019","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0020","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4137\/PMC.S13384","article-title":"Pathways for small molecule delivery to the central nervous system across the blood-brain barrier","volume":"6","author":"Mikitsh","year":"2014","journal-title":"Perspect Medicin Chem."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0025","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1021\/mp300495e","article-title":"Diffusion of macromolecules in the brain: implications for drug delivery","volume":"10","author":"Wolak","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tox.2007.04.005","article-title":"Regulatory perspectives of type II prodrug development and time-dependent toxicity management: nonclinical pharm\/Tox analysis and the role of comparative toxicology","volume":"236","author":"Wu","year":"2007","journal-title":"Toxicology"},{"key":"10.1016\/j.jconrel.2022.08.051_bb0035","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1158\/2159-8290.CD-17-0698","article-title":"Endothelial activation and blood-brain barrier disruption in neurotoxicity after adoptive immunotherapy with CD19 CAR-T cells","volume":"7","author":"Gust","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0040","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.tips.2017.09.002","article-title":"Challenges and recent advances in Medulloblastoma therapy","volume":"38","author":"Kumar","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0045","doi-asserted-by":"crossref","first-page":"18220","DOI":"10.1038\/s41598-020-75253-9","article-title":"Investigating the optimum size of nanoparticles for their delivery into the brain assisted by focused ultrasound-induced blood-brain barrier opening","volume":"10","author":"Ohta","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0050","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.actbio.2017.10.034","article-title":"Surface-adaptive zwitterionic nanoparticles for prolonged blood circulation time and enhanced cellular uptake in tumor cells","volume":"65","author":"Ou","year":"2018","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0055","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12987-020-00209-0","article-title":"Differential expression of receptors mediating receptor-mediated transcytosis (RMT) in brain microvessels, brain parenchyma and peripheral tissues of the mouse and the human","volume":"17","author":"Zhang","year":"2020","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.jconrel.2022.08.051_bb0060","doi-asserted-by":"crossref","first-page":"19141","DOI":"10.1073\/pnas.2002016117","article-title":"Targeting nanoparticles to the brain by exploiting the blood-brain barrier impermeability to selectively label the brain endothelium","volume":"117","author":"Gonzalez-Carter","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0065","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.1002\/anie.201411408","article-title":"Applying the retro-enantio approach to obtain a peptide capable of overcoming the blood-brain barrier","volume":"54","author":"Prades","year":"2015","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0070","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1158\/1078-0432.CCR-19-3258","article-title":"ANG1005, a brain-penetrating peptide-drug conjugate, shows activity in patients with breast cancer with Leptomeningeal Carcinomatosis and recurrent brain metastases","volume":"26","author":"Kumthekar","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0075","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.563938","article-title":"Dual-target peptide-modified erythrocyte membrane-enveloped PLGA nanoparticles for the treatment of Glioma","volume":"10","author":"Cui","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0080","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.3389\/fnins.2018.01019","article-title":"Transcytosis to cross the blood brain barrier, new advancements and challenges","volume":"12","author":"Pulgar","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0085","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1021\/mp1001729","article-title":"BCRP at the blood-brain barrier: genomic regulation by 17beta-estradiol","volume":"7","author":"Mahringer","year":"2010","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0090","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1741-7015-2-37","article-title":"Significance of MDR1 and multiple drug resistance in refractory human epileptic brain","volume":"2","author":"Marchi","year":"2004","journal-title":"BMC Med."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0095","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3389\/fncel.2019.00282","article-title":"Pericytes and neurovascular function in the healthy and diseased brain","volume":"13","author":"Brown","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0100","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nn.4288","article-title":"Pericytes of the neurovascular unit: key functions and signaling pathways","volume":"19","author":"Sweeney","year":"2016","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0105","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nature09522","article-title":"Pericytes regulate the blood-brain barrier","volume":"468","author":"Armulik","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2022.08.051_bb0110","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/JLB.1RU1117-428R","article-title":"Blood-brain barrier and its function during inflammation and autoimmunity","volume":"103","author":"Sonar","year":"2018","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0115","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1177\/0271678X20951995","article-title":"Regulation of blood-brain barrier integrity by microglia in health and disease: a therapeutic opportunity","volume":"40","author":"Ronaldson","year":"2020","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0120","doi-asserted-by":"crossref","first-page":"5816","DOI":"10.1038\/s41467-019-13812-z","article-title":"Dual microglia effects on blood brain barrier permeability induced by systemic inflammation","volume":"10","author":"Haruwaka","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0125","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/978-1-62703-520-0_27","article-title":"Analyses of microglia effector function using CX3CR1-GFP knock-in mice","volume":"1041","author":"Garcia","year":"2013","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0130","doi-asserted-by":"crossref","first-page":"1651157","DOI":"10.1080\/21688370.2019.1651157","article-title":"The extracellular matrix of the blood-brain barrier: structural and functional roles in health, aging, and Alzheimer's disease","volume":"7","author":"Reed","year":"2019","journal-title":"Tissue Barriers"},{"key":"10.1016\/j.jconrel.2022.08.051_bb0135","doi-asserted-by":"crossref","first-page":"218S","DOI":"10.1093\/jn\/136.1.218S","article-title":"Structure of the blood-brain barrier and its role in the transport of amino acids","volume":"136","author":"Hawkins","year":"2006","journal-title":"J. Nutr."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0140","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1097\/01.jnen.0000173894.09553.13","article-title":"Basement membrane proteins in multiple sclerosis-associated inflammatory cuffs: potential role in influx and transport of leukocytes","volume":"64","author":"van Horssen","year":"2005","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0145","series-title":"Neuroanatomy, Choroid Plexus, in: StatPearls, Treasure Island (FL)","author":"Javed","year":"2022"},{"key":"10.1016\/j.jconrel.2022.08.051_bb0150","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00281-009-0177-0","article-title":"The blood-brain and the blood-cerebrospinal fluid barriers: function and dysfunction","volume":"31","author":"Engelhardt","year":"2009","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0155","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/2045-8118-8-3","article-title":"Molecular biology of the blood-brain and the blood-cerebrospinal fluid barriers: similarities and differences","volume":"8","author":"Redzic","year":"2011","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.jconrel.2022.08.051_bb0160","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/path.5510","article-title":"The choroid plexus stroma constitutes a sanctuary for paediatric B-cell precursor acute lymphoblastic leukaemia in the central nervous system","volume":"252","author":"Fernandez-Sevilla","year":"2020","journal-title":"J. Pathol."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0165","article-title":"Physiological and pathological factors affecting drug delivery to the brain by nanoparticles","volume":"8","author":"Islam","year":"2021","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.jconrel.2022.08.051_bb0170","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12974-021-02370-1","article-title":"Immune response and pathogen invasion at the choroid plexus in the onset of cerebral toxoplasmosis","volume":"19","author":"Figueiredo","year":"2022","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jconrel.2022.08.051_bb0175","series-title":"The Rat Nervous System (Fourth Edition)","first-page":"315","article-title":"Circumventricular organs","author":"Brian","year":"2015"},{"key":"10.1016\/j.jconrel.2022.08.051_bb0180","series-title":"Williams Textbook of Endocrinology","first-page":"114","article-title":"Neuroendocrinology","author":"Lechan","year":"2020"},{"key":"10.1016\/j.jconrel.2022.08.051_bb0185","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.tins.2020.12.002","article-title":"Blood-brain barrier dynamics to maintain brain homeostasis","volume":"44","author":"Segarra","year":"2021","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0190","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/bs.apha.2014.06.011","article-title":"Blood-brain barrier Na transporters in ischemic stroke","volume":"71","author":"O\u2019Donnell","year":"2014","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0195","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.3389\/fpsyg.2015.01520","article-title":"Neurotransmitters as food supplements: the effects of GABA on brain and behavior","volume":"6","author":"Boonstra","year":"2015","journal-title":"Front. Psychol."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0200","doi-asserted-by":"crossref","first-page":"867S","DOI":"10.3945\/ajcn.2009.27462BB","article-title":"The blood-brain barrier and glutamate","volume":"90","author":"Hawkins","year":"2009","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0205","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/syn.890010111","article-title":"Serum protein leakage in aged human brain and inhibition of ligand binding at alpha 2-adrenergic and cholinergic binding sites","volume":"1","author":"Pappolla","year":"1987","journal-title":"Synapse"},{"key":"10.1016\/j.jconrel.2022.08.051_bb0210","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/00001721-199704000-00003","article-title":"Prothrombin conversion under flow conditions by prothrombinase assembled on adherent platelets","volume":"8","author":"Billy","year":"1997","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.jconrel.2022.08.051_bb0215","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23010337","article-title":"The plasminogen-activator plasmin system in physiological and pathophysiological angiogenesis","volume":"23","author":"Ismail","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0220","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/978-3-319-96445-4_13","article-title":"Transport across the blood-brain barrier","volume":"1097","author":"Fu","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0225","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1080\/10715760902751902","article-title":"Involvement of ROS in BBB dysfunction","volume":"43","author":"Pun","year":"2009","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0230","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.bbr.2017.01.012","article-title":"Anti-RAGE antibody attenuates isoflurane-induced cognitive dysfunction in aged rats","volume":"322","author":"Shi","year":"2017","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0235","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.63253","article-title":"Nano-scale architecture of blood-brain barrier tight-junctions","volume":"10","author":"Sasson","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.jconrel.2022.08.051_bb0240","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1007\/s00018-019-03030-7","article-title":"Tight junction proteins at the blood-brain barrier: far more than claudin-5","volume":"76","author":"Berndt","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0245","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1096\/fj.15-277673","article-title":"Occludin controls HIV transcription in brain pericytes via regulation of SIRT-1 activation","volume":"30","author":"Castro","year":"2016","journal-title":"FASEB J."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0250","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/nyas.13359","article-title":"Claudin peptidomimetics modulate tissue barriers for enhanced drug delivery","volume":"1397","author":"Dithmer","year":"2017","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0255","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.nbd.2018.07.030","article-title":"A differentiating neural stem cell-derived astrocytic population mitigates the inflammatory effects of TNF-alpha and IL-6 in an iPSC-based blood-brain barrier model","volume":"119","author":"Mantle","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0260","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.molimm.2017.09.020","article-title":"Wip1 regulates blood-brain barrier function and neuro-inflammation induced by lipopolysaccharide via the sonic hedgehog signaling signaling pathway","volume":"93","author":"Zhen","year":"2018","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0265","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1124\/jpet.107.127035","article-title":"Cyclooxygenase inhibition limits blood-brain barrier disruption following intracerebral injection of tumor necrosis factor-alpha in the rat","volume":"323","author":"Candelario-Jalil","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0270","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00018-015-2050-8","article-title":"Factors controlling permeability of the blood-brain barrier","volume":"73","author":"Almutairi","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0275","article-title":"Effects of natural polyphenols on oxidative stress-mediated blood-brain barrier dysfunction","volume":"11","author":"Kim","year":"2022","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.jconrel.2022.08.051_bb0280","first-page":"F326","article-title":"Estradiol 17 beta-D-glucuronide is a high-affinity substrate for oatp organic anion transporter","volume":"270","author":"Kanai","year":"1996","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0285","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.dmpk.2014.12.009","article-title":"Dehydroepiandrosterone sulfate, a useful endogenous probe for evaluation of drug-drug interaction on hepatic organic anion transporting polypeptide (OATP) in cynomolgus monkeys","volume":"30","author":"Watanabe","year":"2015","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.jconrel.2022.08.051_bb0290","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/2045-8118-10-29","article-title":"Localization of organic anion transporting polypeptide (Oatp) 1a4 and Oatp1c1 at the rat blood-retinal barrier","volume":"10","author":"Akanuma","year":"2013","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.jconrel.2022.08.051_bb0295","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1124\/dmd.117.079483","article-title":"Organic anion transporting polypeptide 1a4 is responsible for the hepatic uptake of cardiac glycosides in mice","volume":"46","author":"Takano","year":"2018","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0300","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1124\/jpet.110.174151","article-title":"Inflammatory pain signals an increase in functional expression of organic anion transporting polypeptide 1a4 at the blood-brain barrier","volume":"336","author":"Ronaldson","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0305","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.dmpk.2014.12.006","article-title":"Memantine transport by a proton-coupled organic cation antiporter in hCMEC\/D3 cells, an in vitro human blood-brain barrier model","volume":"30","author":"Higuchi","year":"2015","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.jconrel.2022.08.051_bb0310","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.4088\/JCP.08m04307yel","article-title":"Positron emission tomography measurement of dopamine D(2) receptor occupancy in the pituitary and cerebral cortex: relation to antipsychotic-induced hyperprolactinemia","volume":"71","author":"Arakawa","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jconrel.2022.08.051_bb0315","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s11307-012-0556-0","article-title":"P-glycoprotein function at the blood-brain barrier: effects of age and gender","volume":"14","author":"van Assema","year":"2012","journal-title":"Mol. Imaging Biol."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0320","doi-asserted-by":"crossref","first-page":"810","DOI":"10.2174\/1871520616666151120121928","article-title":"Blood-brain barrier and breast cancer resistance protein: a limit to the therapy of CNS tumors and neurodegenerative diseases","volume":"16","author":"Iorio","year":"2016","journal-title":"Anti Cancer Agents Med. Chem."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0325","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1158\/0008-5472.CAN-04-2416","volume":"65","author":"Breedveld","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0330","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1124\/jpet.109.154781","article-title":"P-glycoprotein and breast cancer resistance protein influence brain distribution of dasatinib","volume":"330","author":"Chen","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0335","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.exger.2017.12.019","article-title":"Role of the peripheral innate immune system in the development of Alzheimer\u2019s disease","volume":"107","author":"Le Page","year":"2018","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0340","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.bbi.2009.01.017","article-title":"Lipopolysaccharide alters the blood-brain barrier transport of amyloid beta protein: a mechanism for inflammation in the progression of Alzheimer\u2019s disease","volume":"23","author":"Jaeger","year":"2009","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0345","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1016\/j.neurobiolaging.2013.02.010","article-title":"Increased blood-brain barrier vulnerability to systemic inflammation in an Alzheimer disease mouse model","volume":"34","author":"Takeda","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jconrel.2022.08.051_bb0350","doi-asserted-by":"crossref","first-page":"398","DOI":"10.3389\/fncel.2018.00398","article-title":"Peripheral inflammation enhances microglia response and Nigral dopaminergic cell death in an in vivo MPTP model of Parkinson\u2019s disease","volume":"12","author":"Garcia-Dominguez","year":"2018","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0355","article-title":"Peripheral inflammation promotes brain tau transmission via disrupting blood-brain barrier","volume":"40","author":"Liu","year":"2020","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107758","article-title":"Antioxidant and anti-inflammatory effects of dexrazoxane on dopaminergic neuron degeneration in rodent models of Parkinson's disease","volume":"160","author":"Mei","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jconrel.2022.08.051_bb0365","doi-asserted-by":"crossref","first-page":"5656","DOI":"10.1073\/pnas.0701252104","article-title":"Loss of blood-brain barrier integrity in the spinal cord is common to experimental allergic encephalomyelitis in knockout mouse models","volume":"104","author":"Fabis","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0370","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aai7696","article-title":"Astrocyte-shed extracellular vesicles regulate the peripheral leukocyte response to inflammatory brain lesions","volume":"10","author":"Dickens","year":"2017","journal-title":"Sci. Signal."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0375","doi-asserted-by":"crossref","first-page":"5664","DOI":"10.1158\/1078-0432.CCR-10-1564","article-title":"Heterogeneous blood-tumor barrier permeability determines drug efficacy in experimental brain metastases of breast cancer","volume":"16","author":"Lockman","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0380","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1021\/acsnano.6b08244","article-title":"Mechanisms and barriers in cancer Nanomedicine: addressing challenges, looking for solutions","volume":"11","author":"Anchordoquy","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2022.08.051_bb0385","first-page":"252","article-title":"Glioblastoma: defining tumor niches, trends","volume":"1","author":"Hambardzumyan","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.jconrel.2022.08.051_bb0390","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/cns.13081","article-title":"The peripheral immune response after stroke-a double edge sword for blood-brain barrier integrity","volume":"24","author":"Li","year":"2018","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0395","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1177\/0271678X19841443","article-title":"Systemic inflammation in hemorrhagic strokes - a novel neurological sign and therapeutic target?","volume":"39","author":"Saand","year":"2019","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0400","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s12031-018-1173-4","article-title":"Immune cells after ischemic stroke onset: roles, migration, and target intervention","volume":"66","author":"Ao","year":"2018","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0405","doi-asserted-by":"crossref","first-page":"853","DOI":"10.3389\/fneur.2019.00853","article-title":"Inhibition of CD147 attenuates stroke-associated pneumonia through modulating lung immune response in mice","volume":"10","author":"Jin","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0410","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1084\/jem.20021098","article-title":"Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation","volume":"198","author":"Prass","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0415","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3892\/mmr.2013.1875","article-title":"The role of claudin-5 in blood-brain barrier (BBB) and brain metastases (review)","volume":"9","author":"Jia","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0420","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0236770","article-title":"The blood-brain barrier studied in vitro across species","volume":"16","author":"Thomsen","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2022.08.051_bb0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121470","article-title":"Effect of magnesium stearate surface coating method on the aerosol performance and permeability of micronized fluticasone propionate","volume":"615","author":"Kumar","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0430","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41467-019-13896-7","article-title":"Microengineered human blood-brain barrier platform for understanding nanoparticle transport mechanisms","volume":"11","author":"Ahn","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0435","doi-asserted-by":"crossref","first-page":"15222","DOI":"10.1038\/srep15222","article-title":"Three-dimensional blood-brain barrier model for in vitro studies of neurovascular pathology","volume":"5","author":"Cho","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0440","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/jcbfm.2010.162","article-title":"A dynamic in vitro BBB model for the study of immune cell trafficking into the central nervous system","volume":"31","author":"Cucullo","year":"2011","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0445","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3389\/fonc.2019.00351","article-title":"A novel three-dimensional Glioma blood-brain barrier model for high-throughput testing of Tumoricidal capability","volume":"9","author":"Sherman","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0450","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.biomaterials.2018.07.014","article-title":"3D self-organized microvascular model of the human blood-brain barrier with endothelial cells, pericytes and astrocytes","volume":"180","author":"Campisi","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2022.08.051_bb0455","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.cell.2016.05.082","article-title":"Modeling development and disease with Organoids","volume":"165","author":"Clevers","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2022.08.051_bb0460","article-title":"In vitro models of the blood-brain barrier: tools in translational medicine","volume":"2","author":"Williams-Medina","year":"2020","journal-title":"Front. Med. Technol."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0465","doi-asserted-by":"crossref","first-page":"7413","DOI":"10.1038\/s41598-018-25603-5","article-title":"Human cortex spheroid with a functional blood brain barrier for high-throughput neurotoxicity screening and disease modeling","volume":"8","author":"Nzou","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0470","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41592-018-0070-7","article-title":"Genetically engineered cerebral organoids model brain tumor formation","volume":"15","author":"Bian","year":"2018","journal-title":"Nat. Methods"},{"key":"10.1016\/j.jconrel.2022.08.051_bb0475","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.celrep.2018.03.105","article-title":"Glioblastoma Model Using Human Cerebral Organoids","volume":"23","author":"Ogawa","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0480","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41467-019-13989-3","article-title":"Modeling medulloblastoma in vivo and with human cerebellar organoids","volume":"11","author":"Ballabio","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0485","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/j.ejca.2012.12.028","article-title":"Sildenafil is not a useful modulator of ABCB1 and ABCG2 mediated drug resistance in vivo","volume":"49","author":"Lin","year":"2013","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.jconrel.2022.08.051_bb0490","series-title":"The Practice of Medicinal Chemistry (Fourth Edition)","first-page":"631","article-title":"Strategies for enhancing oral bioavailability and brain penetration","author":"Gross","year":"2015"},{"key":"10.1016\/j.jconrel.2022.08.051_bb0495","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111571","article-title":"Novel derivatives of anaplastic lymphoma kinase inhibitors: synthesis, radiolabeling, and preliminary biological studies of fluoroethyl analogues of crizotinib, alectinib, and ceritinib","volume":"182","author":"Radaram","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0500","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115562","article-title":"Fibroblast growth factor receptor modulators employing diamines with reduced phospholipidosis-inducing potential","volume":"28","author":"Sakai","year":"2020","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0505","doi-asserted-by":"crossref","first-page":"4915","DOI":"10.1021\/acs.jmedchem.8b01630","article-title":"Discovery of potent, selective, and brain-penetrant 1 H-Pyrazol-5-yl-1 H-pyrrolo[2,3- b]pyridines as anaplastic lymphoma kinase (ALK) inhibitors","volume":"62","author":"Fushimi","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0510","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/nature08893","article-title":"N-myristoyltransferase inhibitors as new leads to treat sleeping sickness","volume":"464","author":"Frearson","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2022.08.051_bb0515","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1021\/acsmedchemlett.9b00599","article-title":"Development of a potent brain-penetrant EGFR tyrosine kinase inhibitor against malignant brain tumors","volume":"11","author":"Tsang","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0520","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1021\/cn100008c","article-title":"Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties","volume":"1","author":"Wager","year":"2010","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0525","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1016\/j.xphs.2019.02.005","article-title":"Validation of human MDR1-MDCK and BCRP-MDCK cell lines to improve the prediction of brain penetration","volume":"108","author":"Feng","year":"2019","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0530","article-title":"Lipid polymeric nanoparticles modified with tight junction-modulating peptides promote afatinib delivery across a blood\u2013brain barrier model","volume":"12","author":"Yu-Li Lo","year":"2021","journal-title":"Cancer Nanotechnol."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0535","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s11060-010-0124-x","article-title":"Bradykinin increases the permeability of the blood-tumor barrier by the caveolae-mediated transcellular pathway","volume":"99","author":"Liu","year":"2010","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0540","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abb4429","article-title":"Neurotransmitter-derived lipidoids (NT-lipidoids) for enhanced brain delivery through intravenous injection","volume":"6","author":"Ma","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0545","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.ultrasmedbio.2007.11.009","article-title":"Effects of acoustic parameters and ultrasound contrast agent dose on focused-ultrasound induced blood-brain barrier disruption","volume":"34","author":"McDannold","year":"2008","journal-title":"Ultrasound Med. Biol."},{"issue":"12","key":"10.1016\/j.jconrel.2022.08.051_bb0550","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1016\/j.ymthe.2018.08.022","article-title":"Therapeutic potential of OMe-PS-miR-29b1 for treating liver fibrosis","volume":"26","author":"Kumar","year":"2018","journal-title":"Mol.Ther."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0555","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abf7390","article-title":"Single-cell analysis reveals effective siRNA delivery in brain tumors with microbubble-enhanced ultrasound and cationic nanoparticles","volume":"7","author":"Guo","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0560","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.1200\/JCO.2005.07.144","article-title":"Use of magnetic resonance imaging to assess blood-brain\/blood-glioma barrier opening during conformal radiotherapy","volume":"23","author":"Cao","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0565","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13010039","article-title":"Convection enhanced delivery of Topotecan for Gliomas: a single-center experience","volume":"13","author":"Upadhyayula","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2022.08.051_bb0570","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/s41596-021-00634-x","article-title":"Hyperosmolar blood-brain barrier opening using intra-arterial injection of hyperosmotic mannitol in mice under real-time MRI guidance","volume":"17","author":"Chu","year":"2022","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0575","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1586\/14737140.2013.840090","article-title":"The role of Gliadel wafers in the treatment of high-grade gliomas","volume":"13","author":"Bregy","year":"2013","journal-title":"Expert. Rev. Anticancer. Ther."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0580","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3389\/fcvm.2019.00051","article-title":"Low density lipoprotein receptor-related Protein-1 in cardiac inflammation and infarct healing","volume":"6","author":"Potere","year":"2019","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0585","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1111\/j.1471-4159.2008.05492.x","article-title":"Involvement of the low-density lipoprotein receptor-related protein in the transcytosis of the brain delivery vector angiopep-2","volume":"106","author":"Demeule","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0590","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1124\/jpet.107.131318","article-title":"Identification and design of peptides as a new drug delivery system for the brain","volume":"324","author":"Demeule","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0595","doi-asserted-by":"crossref","first-page":"10949","DOI":"10.2147\/CMAR.S235776","article-title":"Matrilysins and Stromelysins in pathogenesis and diagnostics of cancers","volume":"12","author":"Piskor","year":"2020","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0600","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1161\/STROKEAHA.113.002274","article-title":"MMP9 variation after thrombolysis is associated with hemorrhagic transformation of lesion and death","volume":"44","author":"Inzitari","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/j.jconrel.2022.08.051_bb0605","doi-asserted-by":"crossref","first-page":"3134","DOI":"10.1016\/j.xphs.2020.06.021","article-title":"Development of brain targeting peptide based MMP-9 inhibiting nanoparticles for the treatment of brain diseases with elevated MMP-9 activity","volume":"109","author":"Islam","year":"2020","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0610","doi-asserted-by":"crossref","first-page":"5482","DOI":"10.1002\/anie.201100875","article-title":"Micelle-based brain-targeted drug delivery enabled by a nicotine acetylcholine receptor ligand","volume":"50","author":"Zhan","year":"2011","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0615","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121138","article-title":"Polymeric nanomedicine for overcoming resistance mechanisms in hedgehog and Myc-amplified medulloblastoma","volume":"278","author":"Kumar","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2022.08.051_bb0620","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1038\/s41467-018-04315-4","article-title":"Enhanced efficacy of combined temozolomide and bromodomain inhibitor therapy for gliomas using targeted nanoparticles","volume":"9","author":"Lam","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0625","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1021\/mp500393m","article-title":"Apamin-mediated actively targeted drug delivery for treatment of spinal cord injury: more than just a concept","volume":"11","author":"Wu","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0630","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/anie.201508445","article-title":"MiniAp-4: a venom-inspired Peptidomimetic for brain delivery","volume":"55","author":"Oller-Salvia","year":"2016","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0635","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.4049\/jimmunol.0902214","article-title":"Curvature of synthetic and natural surfaces is an important target feature in classical pathway complement activation","volume":"184","author":"Pedersen","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0640","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.molimm.2014.06.038","article-title":"Complement activation-related pseudoallergy: a stress reaction in blood triggered by nanomedicines and biologicals","volume":"61","author":"Szebeni","year":"2014","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0645","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1039\/C7BM00054E","article-title":"Surface coupling strength of gold nanoparticles affects cytotoxicity towards neurons","volume":"5","author":"Tran","year":"2017","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0650","doi-asserted-by":"crossref","first-page":"14986","DOI":"10.1038\/srep14986","article-title":"Regulating biocompatibility of carbon spheres via defined Nanoscale chemistry and a careful selection of surface functionalities","volume":"5","author":"Misra","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0655","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.tox.2009.01.015","article-title":"The role of nanoparticle size in hemocompatibility","volume":"258","author":"Mayer","year":"2009","journal-title":"Toxicology"},{"key":"10.1016\/j.jconrel.2022.08.051_bb0660","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jconrel.2017.11.043","article-title":"Complement activation in vitro and reactogenicity of low-molecular weight dextran-coated SPIONs in the pig CARPA model: correlation with physicochemical features and clinical information","volume":"270","author":"Fulop","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.08.051_bb0665","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1021\/acsami.6b12932","article-title":"Individually stabilized, Superparamagnetic nanoparticles with controlled Shell and size leading to exceptional stealth properties and high Relaxivities","volume":"9","author":"Lassenberger","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2022.08.051_bb0670","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41565-018-0085-3","article-title":"Nanoparticle-induced neuronal toxicity across placental barriers is mediated by autophagy and dependent on astrocytes","volume":"13","author":"Hawkins","year":"2018","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0675","article-title":"Poly(2-oxazoline) nanoparticle delivery enhances the therapeutic potential of vismodegib for medulloblastoma by improving CNS pharmacokinetics and reducing systemic toxicity","volume":"32","author":"Hwang","year":"2021","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2022.08.051_bb0680","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1039\/C7ME00061H","article-title":"Monocore vs. multicore magnetic iron oxide nanoparticles: uptake by glioblastoma cells and efficiency for magnetic hyperthermia","volume":"2","author":"Hemery","year":"2017","journal-title":"Molecular Sys. Design Eng."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0685","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1002\/adfm.201402289","article-title":"Superparamagnetic liposomes for MRI monitoring and external magnetic field-induced selective targeting of malignant brain tumors","volume":"25","author":"Marie","year":"2015","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0690","doi-asserted-by":"crossref","first-page":"11122","DOI":"10.1038\/s41598-018-29424-4","article-title":"In vivo delineation of glioblastoma by targeting tumor-associated macrophages with near-infrared fluorescent silica coated iron oxide nanoparticles in orthotopic xenografts for surgical guidance","volume":"8","author":"Lee","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0695","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.2147\/IJN.S108329","article-title":"Development of TIMP1 magnetic nanoformulation for regulation of synaptic plasticity in HIV-1 infection","volume":"11","author":"Atluri","year":"2016","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2022.08.051_bb0700","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11060-018-03005-x","article-title":"Combined intracavitary thermotherapy with iron oxide nanoparticles and radiotherapy as local treatment modality in recurrent glioblastoma patients","volume":"141","author":"Grauer","year":"2019","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0705","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.nano.2018.11.015","article-title":"Repolarization of myeloid derived suppressor cells via magnetic nanoparticles to promote radiotherapy for glioma treatment","volume":"16","author":"Wu","year":"2019","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2022.08.051_bb0710","doi-asserted-by":"crossref","first-page":"18837","DOI":"10.1073\/pnas.1111405108","article-title":"Nanoparticles enhance brain delivery of blood-brain barrier-impermeable probes for in vivo optical and magnetic resonance imaging","volume":"108","author":"Koffie","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0715","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1038\/s41467-019-11593-z","article-title":"Brain-targeted drug delivery by manipulating protein corona functions","volume":"10","author":"Zhang","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0720","doi-asserted-by":"crossref","first-page":"4690","DOI":"10.1039\/C6CS00076B","article-title":"Blood-brain barrier shuttle peptides: an emerging paradigm for brain delivery","volume":"45","author":"Oller-Salvia","year":"2016","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0725","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jconrel.2010.11.014","article-title":"Comparison of five different targeting ligands to enhance accumulation of liposomes into the brain","volume":"150","author":"van Rooy","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.08.051_bb0730","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jconrel.2020.04.053","article-title":"ApoE mimetic peptide targeted nanoparticles carrying a BRD4 inhibitor for treating Medulloblastoma in mice","volume":"323","author":"Wang","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.08.051_bb0735","doi-asserted-by":"crossref","first-page":"11070","DOI":"10.1021\/acsnano.8b05265","article-title":"Apolipoprotein E peptide-directed chimeric Polymersomes mediate an ultrahigh-efficiency targeted protein therapy for Glioblastoma","volume":"12","author":"Jiang","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2022.08.051_bb0740","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1158\/1535-7163.MCT-19-0160","article-title":"Improved drug delivery to brain metastases by peptide-mediated Permeabilization of the blood-brain barrier","volume":"18","author":"Aasen","year":"2019","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0745","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.7150\/thno.25228","article-title":"Antibody affinity and valency impact brain uptake of transferrin receptor-targeted gold nanoparticles","volume":"8","author":"Johnsen","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2022.08.051_bb0750","doi-asserted-by":"crossref","first-page":"7194","DOI":"10.1016\/j.biomaterials.2012.06.063","article-title":"Delivery of gold nanoparticles to the brain by conjugation with a peptide that recognizes the transferrin receptor","volume":"33","author":"Prades","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2022.08.051_bb0755","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1021\/acsanm.0c02888","article-title":"Amphiphilic Polymeric Nanoparticles Modified with a Protease-Resistant Peptide Shuttle for the Delivery of SN-38 in Diffuse Intrinsic Pontine Glioma","volume":"4","author":"Alexandra Bukchin","year":"2021","journal-title":"ACS Appl. Nano Mater."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0760","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay1359","article-title":"Brain delivery of therapeutic proteins using an Fc fragment blood-brain barrier transport vehicle in mice and monkeys","volume":"12","author":"Kariolis","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0765","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1021\/mp900235k","article-title":"Pharmacokinetics and brain uptake of a genetically engineered bifunctional fusion antibody targeting the mouse transferrin receptor","volume":"7","author":"Boado","year":"2010","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0770","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.celrep.2017.12.019","article-title":"Brain shuttle antibody for Alzheimer\u2019s disease with attenuated peripheral effector function due to an inverted binding mode","volume":"22","author":"Weber","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0775","article-title":"Trends in the research into immune checkpoint blockade by anti-PD1\/PDL1 antibodies in cancer immunotherapy: a Bibliometric study","volume":"12","author":"Sun","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0780","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.1038\/s41467-019-11719-3","article-title":"Blood-brain barrier permeable nano immunoconjugates induce local immune responses for glioma therapy","volume":"10","author":"Galstyan","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0785","doi-asserted-by":"crossref","first-page":"8505","DOI":"10.1039\/D1RA00550B","article-title":"Application progress of RVG peptides to facilitate the delivery of therapeutic agents into the central nervous system","volume":"11","author":"Wang","year":"2021","journal-title":"RSC Adv."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0790","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121095","article-title":"In vitro and in vivo optimization of liposomal nanoparticles based brain targeted vgf gene therapy","volume":"608","author":"Arora","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0795","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.jconrel.2020.05.048","article-title":"Glucosamine-NISV delivers antibody across the blood-brain barrier: optimization for treatment of encephalitic viruses","volume":"324","author":"Woods","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.08.051_bb0800","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1039\/D0MD00284D","article-title":"Peptide directed phthalocyanine-gold nanoparticles for selective photodynamic therapy of EGFR overexpressing cancers","volume":"12","author":"Goddard","year":"2020","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0805","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1002\/smll.201100628","article-title":"Addressing brain tumors with targeted gold nanoparticles: a new gold standard for hydrophobic drug delivery?","volume":"7","author":"Cheng","year":"2011","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2022.08.051_bb0810","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142071","article-title":"Quorum sensing peptides selectively penetrate the blood-brain barrier","volume":"10","author":"Wynendaele","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2022.08.051_bb0815","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3727\/000000006783980946","article-title":"TAT peptide-modified liposomes provide enhanced gene delivery to intracranial human brain tumor xenografts in nude mice","volume":"16","author":"Gupta","year":"2007","journal-title":"Oncol. Res."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0820","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1021\/bi00682a035","article-title":"Structure-function relationships and site of action of apamin, a neurotoxic polypeptide of bee venom with an action on the central nervous system","volume":"14","author":"Vincent","year":"1975","journal-title":"Biochemistry"},{"key":"10.1016\/j.jconrel.2022.08.051_bb0825","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/bip.22257","article-title":"From venoms to BBB shuttles: synthesis and blood-brain barrier transport assessment of apamin and a nontoxic analog","volume":"100","author":"Oller-Salvia","year":"2013","journal-title":"Biopolymers"},{"key":"10.1016\/j.jconrel.2022.08.051_bb0830","article-title":"Fluorescence-guided tumor visualization using the tumor paint BLZ-100","volume":"100","author":"David","year":"2014","journal-title":"Cureus"},{"issue":"9","key":"10.1016\/j.jconrel.2022.08.051_bb0835","article-title":"Fluorescence-guided tumor visualization using the tumor paint BLZ-100","volume":"6","author":"Kittle","year":"2014","journal-title":"Cureus"},{"key":"10.1016\/j.jconrel.2022.08.051_bb0840","series-title":"Safety and Tolerability Study of 131I-TM-601 to Treat Adult Patients With Recurrent Glioma","author":"NCT00040573","year":"2003"},{"key":"10.1016\/j.jconrel.2022.08.051_bb0845","series-title":"A Safety and Efficacy Study of Intravenous 131I-TM601 in Adult Patients With Malignant Melanoma, in, ClinicalTrials.gov","author":"NCT00733798","year":"2008"},{"key":"10.1016\/j.jconrel.2022.08.051_bb0850","doi-asserted-by":"crossref","DOI":"10.1016\/j.conctc.2021.100830","article-title":"A first-in-human study of BLZ-100 (tozuleristide) demonstrates tolerability and safety in skin cancer patients","volume":"23","author":"Yamada","year":"2021","journal-title":"Contemp. Clin. Trials Commun."},{"key":"10.1016\/j.jconrel.2022.08.051_bb0855","doi-asserted-by":"crossref","first-page":"6200","DOI":"10.1158\/0008-5472.CAN-09-1157","article-title":"Specific targeting of brain tumors with an optical\/magnetic resonance imaging nanoprobe across the blood-brain barrier","volume":"69","author":"Veiseh","year":"2009","journal-title":"Cancer Res."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922005740?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922005740?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:40:51Z","timestamp":1777509651000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365922005740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":171,"alternative-id":["S0168365922005740"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.08.051","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent advances in drug delivery and targeting to the brain","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.08.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}